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Key points 
 
Question: Does improvisational music therapy improve symptom severity of children 
with autism spectrum disorder? 
Findings: In the TIME-A trial of 364 children in nine countries, mean changes of autism 
severity were not significantly different in those randomized to improvisational music therapy 
compared to enhanced standard care, which included parent counseling and other available 
interventions. 
Meaning: In children with autism spectrum disorder, music therapy did not result in 
marked improvements of mean symptom scores compared to enhanced standard care. 
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Abstract 
Importance: Music therapy may facilitate skills in areas affected by autism spectrum 
disorder (ASD) such as social interaction and communication. 
Objective: To evaluate effects of Improvisational Music Therapy (IMT) on generalized 
social communication skills of children with autism spectrum disorder (ASD). 
Design, setting, and participants: Assessor-blinded, international, multicenter, 
randomized clinical trial, conducted in nine countries, of children aged 4 to 7 years with ASD. 
Recruitment November 2011 to November 2015; follow-up January 2012 to November 2016. 
Interventions: Enhanced standard care (ESC; usual care plus parent counseling) versus 
ESC plus IMT (1 or 3 sessions per week), allocated in a 2:1:1 ratio.  
Main outcomes and measures: The primary outcome was symptom severity at 5 
months, based on the Autism Diagnostic Observation Schedule (ADOS), Social Affect 
domain (range 0 to 27; higher scores representing greater severity; minimal clinically 
important difference 1). Prespecified secondary outcomes included parent-rated social 
responsiveness (Social Responsiveness Scale, SRS) and five SRS subscales. All outcomes 
were also assessed at 2 and 12 months. 
Results: Among 364 participants who were randomized (mean age 5.4 years; 83% 
boys), 314 (86%) and 290 (80%) completed the primary and the last endpoint, respectively. 
Over 5 months, those assigned to IMT received a median of 19 IMT, 3 parent counseling, and 
36 other therapy sessions, compared to 3 parent counseling and 45 other therapy sessions in 
those assigned to ESC. From baseline to 5 months, mean scores of ADOS Social Affect 
decreased from 14.08 to 13.23 in the IMT group and from 13.49 to 12.58 in the ESC group 
(mean difference, IMT vs. ESC: 0.06, 95% CI -0.70 to 0.81; P=0.900), with no significant 
difference in improvement. Of six prespecified secondary outcomes, four showed no 
significant difference. IMT was associated with greater improvements than ESC in motivation 
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at 5 months (mean difference, IMT vs. ESC: -0.99, 95% CI -1.97 to -0.01; P=0.050), 
mannerisms at 2 months (mean difference, IMT vs. ESC: -1.2, 95% CI -2.39 to -0.02; 
P=0.048), and mannerisms at 12 months (mean difference, IMT vs. ESC: -1.19, 95% CI -2.37 
to -0.01; P=0.049). Low-intensity IMT was associated with greater improvements than ESC 
in awareness at 2 months (mean difference, IMT vs. ESC: -0.88, 95% CI -1.74 to -0.03; 
P=0.044). High-intensity IMT was associated with greater improvements than ESC in 
mannerisms at 5 months (mean difference, IMT vs. ESC: -1.93, 95% CI -3.37 to -0.48; 
P=0.009). 
Conclusions and relevance: Among children with autism spectrum disorder, 
improvisational music therapy, compared with enhanced standard care, resulted in no 
significant difference in symptom severity based on the ADOS Social Affect domain at 5 
months. These findings do not support the use of IMT for symptom reduction in children with 
autism spectrum disorder.  
Trial registration: ISRCTN registry number: ISRCTN78923965. 
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1. Background  
Autism spectrum disorder (ASD) is characterized by persistent deficits in social 
communication and interaction and restricted, repetitive behaviors and interests.1 ASD affects 
about 1% of the general population and is associated with substantial disability and economic 
loss across the lifespan.2,3 A variety of approaches to improve the core deficits and the lives of 
people with ASD have been developed, including behavioral, developmental, educational, and 
medical interventions,4,5 but the strength of evidence for most interventions is low and only 
some of the many suggested approaches hold promise for reducing autism severity.4 
In the first description of autism, Kanner6 noted that many children with autism had a 
strong preference for music. Music therapy seeks to exploit the potential of music as a 
medium for social communication,7 in analogy to preverbal mother-infant dialogues.8 9 In 
2017 there were about 7000 music therapists in the United States10 and 6000 in Europe.11 In 
improvisational music therapy (IMT), client and therapist spontaneously create music using 
singing, playing, and movement; music is understood in the widest sense. IMT can be 
described as a developmental, child-centered approach where a trained music therapist 
follows the child’s focus of attention, behaviors, and interests to facilitate development in the 
child’s social communicative skills and related areas.12 Randomized trials of limited 
methodological quality have suggested positive effects of music therapy on social interaction, 
joint attention, and parent-child relationships.13 Evidence on longer-term effects and dose-
effect relations is lacking, and evidence that effects observed within therapy sessions 
generalize to other settings, situations and people needs confirmation.13 The objective of this 
study was to evaluate effects of IMT on generalized social communication skills of children 
with ASD. 
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2. Methods 
2.1. Trial design 
The Trial of Improvisational Music therapy's Effectiveness for children with Autism 
(TIME-A) was an assessor-blinded, international, multicenter (10 centers), parallel, pragmatic 
randomized clinical trial that compared IMT added to enhanced standard care (ESC; usual 
care plus parent counseling) with ESC alone for improving social communicative skills in 
children with ASD. Ethics approval was obtained by the relevant ethics committees in each of 
the nine countries worldwide (Australia, Austria, Brazil, Israel, Italy, Korea, Norway, UK, 
USA). Written informed consent was obtained from parents/guardians. An independent data 
monitoring committee monitored safety and examined interim efficacy results. Details of trial 
procedures are published in the study protocol14 and available in Supplement 1. 
 
2.2. Participants and trial procedures 
Trial procedures were piloted to ensure feasibility.15 Children aged 4 years to 6 years 
and 11 months meeting criteria for ASD according to ICD-10 16 were enrolled between 
November 2011 and November 2015 and followed up from January 2012 to November 2016. 
They were eligible if they were not affected by serious sensory disorders (blindness, deafness) 
and had not received music therapy in the last 12 months. Clinical diagnosis was confirmed 
using the ASD cut-off of the Autism Diagnostic Observation Schedule (ADOS)17 and cut-offs 
on two of the three main domains of the Autism Diagnostic Interview-Revised (ADI-R).18 
Cognitive ability was assessed using the Kaufman Assessment Battery for Children (K-
ABC)19 or another IQ test, or by clinical judgment when the child was unable to complete a 
formal test. Participating parents/guardians completed the Social Responsiveness Scale 
(SRS)20 and two 100mm visual analog scales for quality of life of the participant and the 
family. Demographic characteristics and information on concomitant treatments were also 
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collected from parents. Follow-up assessments at 2, 5, and 12 months after randomization 
included ADOS, SRS, quality of life, and concomitant treatments; at 12 months we also 
assessed success of blinding and reason for potential drop-out. 
After consent and baseline assessments, participants were randomly assigned to one of 
three conditions: low-intensity IMT (once per week) plus ESC, high-intensity IMT (three 
times per week) plus ESC, or ESC alone over a period of five months. Participants were free 
to attend any type of treatment or therapeutic interventions, but were asked not to attend 
music therapy outside the study context. 
Individuals were randomly assigned according to a computer generated randomization 
list with a ratio 1:1:2 (low-intensity IMT : high-intensity IMT : ESC), stratified by site and 
with randomly varying block sizes of 4 and 8, which was prepared by an investigator with no 
clinical involvement. When site investigators had enrolled a new participants, a coordinator 
(ŁB) with no clinical involvement checked eligibility and baseline data before handing out the 
randomization via an online system. 
All data were stored on an electronic database management system on a secure server 
with password-controlled access (OpenClinica, version 3.3) and double-entered 




Improvisational Music Therapy (IMT) 
IMT was offered in outpatient settings (clinics, kindergartens, family homes) in 30-
minute one-to-one sessions (possibly joined by family members). Depending on the 
randomization to high- or low-intensity IMT, either one or three weekly sessions were offered 
for a period of five months. IMT was conducted by 30 qualified music therapists (21 female; 
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mean age 34.7 years, range 23 to 55 years; mean experience as music therapists 7.3 years, 
range 0 to 30 years) with clinical experience of working with children with ASD. IMT was 
conducted in accordance with eight consensus principles described in detail separately12 and 
summarized in Table S4. Therapists developed joint musical activities (singing or 
instrumental play) individually with each child, based on the child’s focus of attention, using 
improvisation techniques such as synchronizing, mirroring, or grounding. These activities 
aimed to develop and enhance affect sharing and joint attention, which are associated with 
development of social competencies in ASD.14 Sessions were videotaped or audiotaped for 
independent fidelity assessment.12,14  
Enhanced Standard Care (ESC) 
ESC consisted of the routine care available at the site plus three 60-minute sessions of 
parent counseling (at intake and after 2 and 5 months), based on general principles described 
in the protocol.14 Parent counseling was conducted by 24 parent counselors experienced with 
ASD (20 female; clinical psychologists, social workers, or music therapists) in accordance 
with the study protocol.14 Sessions were videotaped when possible. 
 
2.4. Outcomes 
The primary outcome was the Social Affect (SA) score of the ADOS,17 a measure of 
autism symptom severity, at 5 months. The ADOS is a semi-structured, standardized 
observation instrument designed to assess autism symptoms. It is regarded as the gold 
standard of ASD diagnosis21 and has also been used in intervention trials.22-27 In the 
population relevant for this trial, one of three modules and one of five scoring algorithms is 
chosen, depending on language abilities and age. Of a total of 28 to 31 ADOS items, 10 are 
used to calculate the ADOS SA score. Items can range from 0 to 2 or 3; in line with an earlier 
trial,27 the full range of item scores from 0-3 was retained to improve sensitivity to change. 
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We applied the same module across time points for each child to ensure consistency.14 The 
ADOS SA score, constructed as the sum of the relevant items for the Social Affect domain, 
can range from 0 to 27 (module 3; 0 to 24 in modules 1 and 2), with higher scores indicating 
greater severity. We assumed a minimal clinically important difference (MCID) of 1 point, 
corresponding to a small effect size (Cohen’s d=0.2, assuming SD=5).14 We used the most 
current version available in all countries/languages.17 A later revised version, the ADOS-2, 
was not used because it had not been translated into all relevant languages. Similarly, formal 
training in ADOS assessments was available in some but not all countries. All assessors in 
Australia, Korea, and the UK had completed research level qualification (the highest level); 
those in Israel, Italy, Norway, and the USA had at least clinical level qualification (the basic 
level). In Austria and Brazil, no certification was available, but we used experienced ADOS 
raters. Of the 23 assessors, 10 had research training and 10 had clinical training. We used 
assessors from different location who were not normally involved with the child to ensure 
blinding. Success of blinding was verified by asking assessors if and how they had discovered 
the child’s allocation. 
Prespecified secondary outcomes 
Secondary outcomes were the Social Responsiveness Scale (SRS) total scale and its five 
subscales. The SRS is a parent-rated measure and was therefore not blinded. A total of 65 
items (each ranging from 0 “not true” to 3 “almost always true”) assess the severity of ASD 
symptoms occurring in natural social settings, as observed by parents, for a total score of 0 to 
195. A score of 85 or above provides strong evidence of the presence of an ASD and is 
recommended for clinical settings, whereas lower cutoffs are recommended for screening.20 
The subscales social awareness, social cognition, social communication, social motivation, 
and autistic mannerisms include 8 to 22 items each.20 Secondary time points were two and 
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twelve months after randomization. An additional outcome, cost-effectiveness, will be 
reported separately. 
Additional exploratory outcomes 
Not mentioned in the original protocol, we also analyzed as additional exploratory 
outcomes: the ADOS total score and subscales; two 100mm visual analogue scales for quality 
of life of the child and of the family as a whole (0 = worst to 100 = best possible quality of 
life); and adverse events. 
2.5.  Sample size and power 
The study was originally conceived as a group sequential design with four interim 
analyses to detect an MCID of 1 point on ADOS SA,14 but was stopped after the first 
prespecified analysis (see Results). As conducted, it had 42% power to detect a difference of 
1 point, or 80% power for a difference of 1.6 points. 
2.6.  Statistical analyses 
The main statistical analysis14 followed the intention-to-treat (ITT) principle as closely 
as possible by including all participants who had data of at least one follow-up time point in 
the group to which they had originally been randomized. Analyses compared mean change on 
the primary outcome in longitudinal models, following confirmation of normality. We 
calculated linear mixed effects models (LMEs) with maximum likelihood estimation, both 
unadjusted and adjusted for site as a random effect, for the main two-arm comparison and the 
three-arm comparison including intensity of IMT, with treatment effects represented as 
interaction effects (time x group). Sensitivity analyses for the primary outcome and 
comparison tested the influence of missing data (linear models on 50 data sets multiply 
imputed using diagnosis, age, and site) and therapist effects (LME with music therapist as a 
random effect nested within site). Prespecified subgroup analyses were conducted for sex and 
ASD subtype using linear models with interaction tests. 
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Secondary outcomes were analyzed using LMEs. Because no adjustments for multiple 
testing were made, all secondary outcomes (both prespecified and other) were regarded as 
exploratory. No statistical analysis was conducted for exploratory adverse events. 
In a post hoc “responder analysis”28 we compared the proportion of participants who 
improved by at least the MCID on the primary outcome. In this binary ITT analysis, we 
included all participants randomized, assuming no improvements for missing data. We 
calculated risk ratios with two-sided 95% confidence intervals using Wald unconditional 
maximum likelihood estimation for the ITT sample, the per-protocol sample, and exploratory 
subgroups (sex, age, ASD subtype, verbal ability, symptom severity, cognitive ability, 
country, time of enrolment). All tests were two-sided with a significance level of 5%. All 
statistical analyses were conducted using R version 3.3.1 (www.r-project.org). Individual 
patient data are available with this article (supplemental material). 
 
3. Results 
3.1. Recruitment and study population 
Of 702 children who were assessed for eligibility, 315 (109 ineligible; 206 declined) 
were excluded prior to baseline assessments and another 23 were found ineligible at baseline, 
before randomization. A total of 364 participants were randomized to IMT or ESC (182 
participants each; Figure 1). Of the 182 children enrolled to IMT, 90 were randomized to 
high-intensity IMT and 92 to low-intensity IMT. The data monitoring committee monitored 
safety regularly and examined the first interim efficacy analysis in September 2015. Although 
the formal criterion for early stopping was not met, the study team decided to stop 
recruitment, in a decision that included considerations of limited funding and therefore 
limited likelihood of successful and timely additional recruitment. Baseline characteristics 
were well balanced between conditions (Table 1; Table S2). Of the 364 participants, 302 were 
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male; 301 were diagnosed with childhood autism; 165 had low cognitive levels (IQ < 70). 
Twelve participants (3%) had prior experience of music therapy. Fifty participants (14%) 
were lost to the five-month follow-up (Figure 1). Baseline characteristics of those who 
dropped out at 5 months were similar to those who were followed up (Table S3). 
Blinding of assessors was broken unintentionally in 20 participants (15 in IMT and 5 in 
ESC), usually due to a parent or other person inadvertently mentioning the intervention. There 
was no evidence of broken or subverted allocation concealment (Figure S1). 
 
3.2. Interventions: Uptake and fidelity 
Concomitant interventions, provided as part of ESC, included speech and language 
therapy or communication training (58%), sensory-motor therapy (incl. occupational and 
physiotherapy; 41%), and a number of other therapies (Table S2). These therapies often 
continued over the course of the trial (Table S2) The median number of sessions of all 
concomitant interventions (not including parent counseling or IMT) over the 5-month 
intervention period was 45 in those allocated to ESC, compared to 36 in those allocated to 
IMT (high-intensity IMT: 31; low-intensity IMT: 40). The parents of 317 (87%) of all 
participants participated in counseling; the median number of sessions was 3 in all groups 
(Figure 1). 
Of those allocated to IMT, 171 (94%) received IMT, with a median of 19 sessions over 
the 5-month period (high-intensity IMT: 34; low-intensity IMT: 15; Figure 1). Missed 
sessions were typically due to holidays or illness (patterns of sessions per week, see Figure 
S2). However, depending on the setting and circumstances, some parents had difficulties with 
bringing their child to therapy three times a week. Treatment fidelity according to the IMT 
manual 12 was adequate in the great majority of sessions: Two independent raters agreed that 
93% (565 of 606 randomly selected 3-minute segments from 63 participants) were conducted 
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adequately (rater 1: 604/606, 100%; rater 2: 566/606, 94%; results of each principle, see 
Table S4). Of those allocated to ESC, none received IMT during the 5-month intervention 
period. However, 1% in each group received music therapy outside the study before the 12-
month follow-up (Figure 1). 
 
3.3. Effects of IMT versus ESC on Social Affect at 5 months: 
Prespecified analyses of the primary outcome 
From baseline to 5 months, mean scores of ADOS Social Affect decreased from 14.08 
to 13.23 in the IMT group and from 13.49 to 12.58 in the ESC group (mean difference, IMT 
vs. ESC: 0.06, 95% CI -0.70 to 0.81; P=0.900; Table 2, upper left part), with no significant 
difference in improvement. Differences in the models adjusted for site were also showed non-
significant (Table S5).  In the three-arm comparison, no significant differences were found 
between high- or low-intensity IMT and ESC (Table 2 lower left part; adjusted model see 
Table S6). Changes over time are shown in Figure 2. Prespecified subgroup analyses did not 
suggest different effects of IMT versus ESC due to sex (P=0.4372) or ASD subtype 
(P=0.871). 
 
3.4. Effects of IMT versus ESC on Social Affect at 2 and 12 months 
No significant differences between IMT and ESC, or between high- or low-intensity 
IMT and ESC, were observed (Table 2, Figure 3). 
  
3.5. Effects of IMT versus ESC: Prespecified secondary outcomes 
Of six prespecified exploratory secondary outcomes, four showed no significant 
difference (Tables S5, S6). SRS total scores are shown in Table 2 and Figure 2. Of the SRS 
subscales, IMT was associated with greater improvements than ESC in motivation at 5 
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months (mean difference, IMT vs. ESC: -0.99, 95% CI -1.97 to -0.01; P=0.050), mannerisms 
at 2 months (mean difference, IMT vs. ESC: -1.2, 95% CI -2.39 to -0.02; P=0.048), and 
mannerisms at 12 months (mean difference, IMT vs. ESC: -1.19, 95% CI -2.37 to -0.01; 
P=0.049). Low-intensity IMT was associated with greater improvements than ESC in 
awareness at 2 months (mean difference, IMT vs. ESC: -0.88, 95% CI -1.74 to -0.03; 
P=0.044). High-intensity IMT was associated with greater improvements than ESC in 
mannerisms at 5 months (mean difference, IMT vs. ESC: -1.93, 95% CI -3.37 to -0.48; 
P=0.009). 
 
3.6.Effects of IMT versus ESC on Social Affect at 5 months: Exploratory analyses 
No significant difference between IMT and ESC was seen in the sensitivity analysis 
using multiple imputation (mean difference, IMT vs. ESC: 0.06, 95% CI -0.61 to 0.72; 
P=0.871) or including the music therapist as a random effect (mean difference, IMT vs. ESC: 
0.05, 95% CI -0.71 to 0.80; P=0.904). 
Exploratory responder analyses indicated a 25% higher proportion of improved cases on 
ADOS Social Affect at 5 months in IMT (95/182, 52%) than in ESC (76/182, 42%; risk ratio 
1.25, 95% CI 1.00 to 1.56, P=0.047; Figure 3). Those who received at least 15 IMT sessions 
had a 39% higher rate of improvement than those in ESC (risk ratio 1.39, 95% CI 1.11 to 
1.74, P=0.004; Figure 3). Among relevant clinical subgroups, males, those with childhood 
autism, and those with low IQ showed statistically significant effects (all P<0.05; risk ratios 
1.28 to 1.43; Figure 3). 
 
3.7. Effects of IMT versus ESC: Additional exploratory outcomes 
Mean changes in participants’ quality of life at 5 months were more positive in high-
intensity IMT than in ESC (mean difference 4.40, 95% CI 0.38 to 8.43, P=0.033; Table S6). 
 - 17 - 
No significant differences were seen at other time points, in family quality of life, ADOS 
total, or any of the other ADOS subscales (Tables S5, S6). 
 
3.8. Adverse events 
Hospitalization or other institutional stay was rare at baseline (9 assigned to IMT and 3 
assigned to ESC had an institutional stay during the last two months). During participation in 
the study, these rates remained stable in ESC (3, 3, and 4; at 2, 5, and 12 months, 
respectively) and decreased in IMT  (6, 6, and 4). These institutional stays were typically 
planned and short-term. No other adverse events or serious adverse events were reported. 
 
4. Discussion  
4.1 Interpretation of findings 
In this international, multicenter clinical trial of children with autism spectrum disorder, 
improvisational music therapy added to enhanced standard care, compared with enhanced 
standard care, resulted in no significant difference in symptom severity based on the ADOS 
Social Affect domain at 5 months. In addition, the amount of improvement in both groups 
was small, and less than the minimal clinically important difference, suggesting that use of 
IMT for children with ASD may not lead to meaningful improvement in symptom severity 
and may not be warranted for improving autistic symptoms. 
Most of the exploratory secondary outcomes were also non-significant. Observed 
differences in social motivation and autistic mannerisms may be due to chance because no 
multiplicity adjustments were made and were not blinded. The exploratory finding of a higher 
proportion of responders in IMT compared to ESC should be interpreted with caution and 
may be biased by differential attrition. No dose effect was found in the prespecified analyses. 
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The findings of the present study contrast with those of previous studies. A systematic 
review of ten clinical trials concluded that music therapy may help children with ASD to 
improve skills in areas constituting the core of the condition.13 It may be that music therapy in 
this international multicenter trial was not applied as consistently as in earlier local trials. 
Alternatively, it may be that previous trials were more successful in matching therapy 
procedures and outcomes. Methodological limitations may also be an explanation. 
None of the previous music therapy trials focused on blinded assessment of core 
symptoms as measured by the ADOS. Designed as a diagnostic measure, this outcome is hard 
to change.29 Few studies have rigorously demonstrated effects of psychosocial interventions 
on generalized behaviors4 using blinded assessments based on the ADOS. An intervention 
focused on parents was found efficacious in a small pilot trial in the UK,22 but in a subsequent 
multicenter trial, effects were not apparent until five years after randomization.25,27 A 
multicenter trial in the US of another parent-mediated intervention observed categorical 
effects on autism severity26 but cautioned that such effects did not match clinical experience. 
Among unblinded studies using ADOS, one found effects of a teacher-directed intervention 
on autism severity,24 whereas another did not find such effects for a child-focused 
developmental intervention, even with more than 1000 treatment hours per child.23 
The number of treatment hours continues to be an important topic in autism intervention 
research. Early claims suggesting benefits with early intensive behavioral intervention have 
not stood up to rigorous randomized evaluations.23,30 The burden associated with attending 
therapy sessions also needs to be considered. In this study, those assigned to IMT tended to 
receive fewer other therapies, possibly in response to the additional offer. Furthermore, not all 
participants were able to attend IMT as frequently as planned. This may raise the question 
how the mode of delivery can be improved to facilitate attendance. 
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Although the present trial did not capture the child’s experience with IMT, it seemed 
very well accepted by parents, children and staff. In a qualitative study connected to this trial, 
parents reported their children’s enjoyment and benefit from IMT and experienced their own 
involvement as positive.31 Developing a consensus regarding principles of IMT ensured some 
consistency across countries, but more work will be needed to improve IMT. Current efforts 
to improve IMT range from improving therapists’ ability to attune optimally to the child32 to 
including family members more actively.33 
4.2 Strengths and limitations 
In comparison to previous smaller studies of music therapy for children with ASD,13 the 
present trial was more generalizable. Inclusion criteria were broad, exclusion criteria minimal; 
ESC was flexible, including a broad and often intensive mix of interventions; IMT was 
delivered by a number of therapists across countries in accordance with international 
consensus guidelines;12 outcomes were assessed in generalized settings and over a longer time 
frame. The large sample size and the blinded assessment of core features are further strengths 
of this study compared to other trials in autism. 
The study was planned with a group sequential design with the possibility of increasing 
the sample to about 1000 to reliably detect a minimal clinically important difference,14 but 
was stopped early. However, the narrow confidence interval around the mean difference may 
ameliorate concerns about insufficient power. 
The duration of intervention and follow-up may have been too short. In routine practice, 
music therapy for children with ASD is often continued for years rather than months. Also 
other interventions for ASD needed five years to show effects on ASD severity.25 In a 
qualitative study, families who participated in music therapy reported continued benefit after 
several years 33. In addition, outcomes concerning wellbeing and adaptive functioning – being 
able to engage in learning, participate successfully in school through childhood and 
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adolescence, and being able to work and have meaningful relationships as adults – may matter 
more to people with ASD than reducing severity.34 Although this study did attempt to involve 
users to some extent, active involvement in choosing outcomes might improve the relevance 
of future studies further. 
4.3 Conclusions 
Among children with autism spectrum disorder, improvisational music therapy, 
compared with enhanced standard care, resulted in no significant difference in symptom 
severity based on the ADOS Social Affect domain at 5 months. These findings do not support 
the use of IMT for symptom reduction in children with autism spectrum disorder.  
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Tables 
 






intensity IMT  
Randomized to low-
intensity IMT 
Characteristics N Value N Value N Value 
Age (years)1 182 5.4 (0.9) 90 5.4 (0.9) 92 5.5 (0.8) 
Sex (m)2 182 149 (81.9%) 90 78 (86.7%) 92 71 (77.2%) 
Native speaker of the country’s 
main language2 182 152 (83.5%) 90 78 (86.7%) 92 74 (80.4%) 
Education mother2 180  89  89  
    <12years  17 (9.4%)  9 (10.1%)  10 (11.2%) 
    ≥12years  64 (35.6%)  37 (41.6%)  31 (34.8%) 
    University  84 (46.7%)  38 (42.7%)  42 (47.2%) 
    Unknown  15 (8.3%)  5 (5.6%)  6 (6.7%) 
Education father2 178  87  89  
    <12years  27 (15.2%)  11 (12.6%)  12 (13.5%) 
    ≥12years  54 (30.3%)  33 (37.9%)  28 (31.5%) 
    University  77 (43.3%)  34 (39.1%)  40 (44.9%) 
    Unknown  20 (11.2%)  9 (10.3%)  9 (10.1%) 
Employment mother2 180  89  89  
    Unemployed or social support  29 (16.1%)  10 (11.2%)  9 (10.1%) 
    Working part-time  41 (22.8%)  29 (32.6%)  22 (24.7%) 
    Working full time  36 (20%)  13 (14.6%)  18 (20.2%) 
    Homemaker  61 (33.9%)  30 (33.7%)  32 (36%) 
    Other  2 (1.1%)  3 (3.4%)  2 (2.2%) 
    Unknown  11 (6.1%)  4 (4.5%)  6 (6.7%) 
Employment father2 179  88  89  
    Unemployed or social support  7 (3.9%)  9 (10.2%)  3 (3.4%) 
    Working part-time  11 (6.1%)  5 (5.7%)  2 (2.2%) 
    Working full time  136 (76%)  58 (65.9%)  70 (78.7%) 
    Homemaker  2 (1.1%)  0 (0%)  3 (3.4%) 
    Other  5 (2.8%)  4 (4.5%)  2 (2.2%) 
    Unknown  18 (10.1%)  12 (13.6%)  9 (10.1%) 
Adults in the household2 174  87  84  
    1 adult  21 (12.1%)  17 (19.5%)  9 (10.7%) 
    2 adults  137 (78.7%)  62 (71.3%)  72 (85.7%) 
    >2 adults  16 (9.2%)  8 (9.2%)  3 (3.6%) 
Siblings in the family2 172  87  83  
    No siblings  56 (32.6%)  16 (18.4%)  18 (21.7%) 
    1 sibling  77 (44.8%)  43 (49.4%)  43 (51.8%) 
    >1 sibling  39 (22.7%)  28 (32.2%)  22 (26.5%) 
Diagnosis2 182  90  92  
    Childhood autism (ICD-10 
code F84.0)  151 (83%)  78 (86.7%)  72 (78.3%) 
    Atypical autism (ICD-10 code 
F84.1)  3 (1.6%)  0 (0%)  0 (0%) 
    Asperger's syndrome (ICD-10 
code F84.5)  8 (4.4%)  2 (2.2%)  4 (4.3%) 
    PDD (ICD-10 code F84.9)3  20 (11%)  10 (11.1%)  16 (17.4%) 
Previous MT, (>12 months ago)2 177 8 (4.5%) 89 7 (7.9%) 90 1 (1.1%) 
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ADOS module2 182  90  92  
    Module1  103 (56.6%)  65 (72.2%)  56 (60.9%) 
    Module2  73 (40.1%)  25 (27.8%)  31 (33.7%) 
    Module3  6 (3.3%)  0 (0%)  5 (5.4%) 
ADOS Total1 181 17.4 (5.2) 90 18.3 (5.1) 92 17.7 (5.7) 
    ADOS Social Affect1 182 13.5 (4.3) 90 14.4 (4.5) 92 13.8 (4.5) 
        ADOS LC1,4 182 3.3 (1.4) 90 3.4 (1.5) 92 3.3 (1.6) 
        ADOS RSI1,5 182 10.2 (3.5) 90 11 (3.5) 92 10.4 (3.7) 
    ADOS RRB1,6 181 3.9 (2) 90 3.9 (2) 92 3.9 (2.2) 
Social Responsiveness (SRS) 
total1 179 96.1 (29.5) 89 95.5 (26.1) 91 96.5 (28.5) 
    SRS awareness1 181 12.4 (4.1) 90 12.2 (3.6) 92 12 (4.1) 
    SRS cognition1 182 18.7 (5.9) 90 18 (5.3) 92 18.4 (6.5) 
    SRS communication1 182 32.1 (10.1) 90 31.9 (9.8) 92 32.4 (10.6) 
    SRS motivation1 182 15 (6.2) 90 15 (5) 92 14.6 (5.7) 
    SRS mannerisms1 182 17.6 (7.1) 90 18.1 (7.3) 92 18.7 (6.9) 
Quality of life, participant1 181 71.1 (18.7) 88 72.3 (18.5) 88 71.9 (18.5) 
Quality of life, family1 181 68 (19.4) 87 68.7 (21.2) 89 67.8 (19.6) 
Parent working reduced hours 
due to the child’s condition (in 
percent of full-time work)1 101 69.1 (31.1) 42 67.9 (29.6) 38 69.5 (30.5) 
IQ source2 182  90  92  
    K-ABC  3 (1.6%)  3 (3.3%)  2 (2.2%) 
    Other standardized test  107 (58.8%)  50 (55.6%)  53 (57.6%) 
    Clinical judgment  72 (39.6%)  37 (41.1%)  37 (40.2%) 
IQ, standardized test1 108 76.1 (27.4) 50 73.4 (27.5) 53 75.9 (22.7) 
Mental retardation (IQ<70)2 180 84 (46.7%) 87 44 (50.6%) 89 40 (44.9%) 
ADI-R A: Reciprocal social 
interaction1 182 18.2 (5.8) 90 18.8 (5.6) 92 18 (5.9) 
ADI-R B: 
Language/communication1 182 13.1 (4.3) 90 13.3 (4.2) 92 12.5 (4) 
ADI-R C: Repetitive 
behaviors/interests1 182 5.9 (2.5) 90 5.9 (2.4) 92 5.8 (2.1) 
ADI-R D: Early onset1 182 3.9 (1.1) 90 4.1 (1) 92 4 (1.1) 
Child care2 182  90  92  
    Attends school  112 (61.5%)  56 (62.2%)  61 (66.3%) 
    Full-time care (≥7h per day)  40 (22%)  19 (21.1%)  21 (22.8%) 
    Part-time care (<7h per day)  19 (10.4%)  13 (14.4%)  6 (6.5%) 
    None of the above   11 (6%)   2 (2.2%)   4 (4.3%) 
1Mean (SD).2N(%). 3Pervasive developmental disorder unspecified. 4Language and communication. 5Reciprocal 
social interaction. 6Restricted and repetitive behavior. 
ADI-R – Autism Diagnostic Interview-Revised (higher scores indicate greater severity); ADOS – Autism 
Diagnostic Observation Schedule (higher scores indicate greater severity); IQ – intelligence quotient (higher 
scores indicate greater cognitive ability); K-ABC – Kaufman Assessment Battery for Children; SRS – Social 
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Table 2. Linear mixed-effects analyses for main outcomes 
 
 ADOS Social Affect (primary outcome)  Social Responsiveness (SRS) total 
Model 1: IMT vs ESC 
Beta 
coefficient 95%CI P-value   
Beta 
coefficient  95%CI P-value 
Intercept 13.49 (12.82, 14.16) <0.001  95.81 (91.58, 100.04) <0.001 
Group (IMT) 0.59 (-0.37, 1.54) .324  0.05 (-5.94, 6.03) .899 
2 months vs. BL -0.38 (-0.96, 0.21) .266  0.47 (-2.67, 3.61) .613 
5 months vs. BL -0.91 (-1.45, -0.36) .001  -1.81 (-4.87, 1.26) .327 
12 months vs. BL -1.63 (-2.20, -1.07) <0.001  -4.61 (-7.70, -1.52) .006 
Group * (2 months vs. BL) 0.21 (-0.59, 1.01) .663  -2.37 (-6.70, 1.95) .230 
Group * (5 months vs. BL) 0.06 (-0.70, 0.81) .900  -3.32 (-7.56, 0.91) .099 
Group * (12 months vs. BL) 0.16 (-0.62, 0.94) .729  -2.47 (-6.77, 1.84) .226 
        
Model 2:  IMT (3x/week), IMT (1x/week) vs ESC 
Beta 
coefficient  95%CI P-value   
Beta 
coefficient  95%CI p-value 
Intercept 13.49 (12.82, 14.16) <0.001  95.81 (91.58, 100.04) <0.001 
IMT-HI (3x/week) vs. ESC 0.91 (-0.26, 2.08) .130  -0.27 (-7.62, 7.09) .859 
IMT-LO (1x/week) vs. ESC 0.27 (-0.89, 1.43) .920  0.35 (-6.95, 7.64) .975 
2 months vs. BL -0.38 (-0.96, 0.21) .266  0.47 (-2.67, 3.60) .614 
5 months vs. BL -0.91 (-1.45, -0.36) .001  -1.81 (-4.86, 1.25) .328 
12 months vs. BL -1.63 (-2.20, -1.07) <0.001  -4.61 (-7.69, -1.52) .006 
(IMT-HI (3x/week) vs. SC) * (2 months vs. BL) 0.21 (-0.78, 1.20) .717  -1.54 (-6.89, 3.81) .501 
(IMT-LO (1x/week) vs. SC) * (2 months vs. BL) 0.22 (-0.73, 1.17) .699  -3.11 (-8.25, 2.03) .201 
(IMT-HI (3x/week) vs. SC) * (5 months vs. BL) -0.24 (-1.18, 0.69) .593  -4.52 (-9.81, 0.76) .076 
(IMT-LO (1x/week) vs. SC) * (5 months vs. BL) 0.34 (-0.57, 1.24) .475  -2.39 (-7.41, 2.63) .309 
(IMT-HI (3x/week) vs. SC) * (12 months vs. BL) 0.18 (-0.78, 1.14) .751  -1.52 (-6.87, 3.84) .524 
(IMT-LO (1x/week) vs. SC) * (12 months vs. BL) 0.15 (-0.78, 1.08) .780   -3.29 (-8.43, 1.85) .188 
Note. BL – baseline; ESC – enhanced standard care; HI – high-intensity; IMT – Improvisational Music Therapy; LO – low-intensity. 
Measures: ADOS Social Affect – possible range 0 to 27, higher scores indicate greater severity. SRS total – possible range 0 to 195, higher scores indicate greater severity. 
Explanation of the model: Intercept – mean value in ESC at baseline. Group (IMT) – difference from Intercept if in IMT. 2 months vs. BL – difference from baseline in ESC 
at 2 months; similar for 5 and 12 months. Group * (2 months vs. BL) – interaction effect, representing the difference between IMT and ESC change from baseline at 2 months 
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(i.e. the treatment effect); similar for 5 and 12 months. The beta coefficients can be added to predict values for each group and time point, e.g. for IMT at 5 months: 
13.49+0.59+(-0.91)+0.06=13.23. 
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Figure captions 
 
Figure 1. Flow of participants through the study 
 
Note. Numbers assessed are based on valid data for the primary outcome. The intermediate assessment at 2 months was optional at UK sites. 
ADI-R – Autism Diagnostic Interview-Revised; ADOS – Autism Diagnostic Observation Schedule; ASD – autism spectrum disorder; ESC – 
enhanced standard care; IMT – improvisational music therapy; K-ABC – Kaufman Assessment Battery for Children; MT – music therapy; PC – 
parent counseling; SRS – Social Responsiveness Scale. 
 
Figure 2. Effects of interventions over time: Predicted mean values from linear mixed-effects models 
 
Figure 3. Effects of IMT vs. ESC on the primary outcome by clinical subgroup: Responders versus non-responders 
 
Note. A responder was defined as being improved by at least the minimally clinically important difference; see Methods. 
Abbreviations: ADOS – Autism Diagnostic Observation Schedule; ASD – autism spectrum disorder; ESC – enhanced standard care; IMT – 
improvisational music therapy. 
